Table 3. Adverse Effects During Intervention Period (Baseline to Week 3).

Variable	No. (%)
	1-Hz rTMS (n = 22)	iTBS (n = 22)	Sham (n = 22)
No adverse effects	6 (27)	10 (45.5)	10 (45.5)
Dizziness	6 (27)	4 (18)	3 (13.5)
Headache or neck pain	6 (27)	10 (45.5)	4 (18)
Fatigue	10 (45.5)	5 (23)	9 (41)
Other	<10 (45.5)a	<10 (45.5)b	<10 (45.5)c

Abbreviations: iTBS, intermittent theta burst stimulation; rTMS, repetitive transcranial magnetic stimulation.

^a Including fatigue and flash of light, combined to avoid compromising data identifiability requirements.

^b Including inner restlessness, pressure on head, burning sensation on skin of head, and memory difficulties, combined to avoid compromising data identifiability requirements.

^c Including eye blinking, bizarre thoughts, suicidal ideation, restlessness, and difficulties swallowing, combined to avoid compromising data identifiability requirements.